Tech Seeker (TS)

diaDexus
Profile last edited on: 9/15/2019

medical diagnostics company
TS Type
Small Corporation
Status
Year Founded
N/A
Last Involved Year
2004

Key People / Management

  Brian Ward -- Chief Exec. Officer, Pres and Director

  Robert Michael Richey -- Chief Bus. Officer

  E. Ralf Schoenbrunner -- Sr. VP of Research and Early Devel.

  Emilia Zychlinsky Bulaevsky -- Chief Technology Officer

Location Information

349 Oyster Point Boulevard
San Francisco, CA 94080
   (650) 246-6400
   www.vaxgen.com,www.diadexus.com

Public Profile

As of July 28, 2010, VaxGen Inc. was acquired by diaDexus, Inc., in a reverse merger transaction. VaxGen, Inc. does not have significant operations. The company seeks to enter into a strategic transaction or series of strategic transactions. Previously, it was engaged in the development of vaccines that immunize against infectious disease. diaDexus, Inc., a life sciences company, focuses on the development and commercialization of proprietary cardiovascular diagnostic products addressing needs in cardiovascular disease. The company?s PLAC Tests, which are provide information to help identify individuals at risk of suffering a heart attack or stroke. It offers PLAC ELISA Test, an aid in predicting risk for coronary heart disease and ischemic strokes associated with atherosclerosis; and PLAC Activity Test, an indicator of atherosclerotic cardiovascular disease. The company markets and distributes its products directly through a sales force to various national and regional clinical reference laboratories in the United States; and through distributors in Europe.

Extent of SBIR involvement

User Avatar

Synopsis: Techseeker Business Condition

Headquartered
USA
Employment
55
Revenue
$0.0B
Public/Private
Publicly Traded
Stock Info
OTC : DDXS
Received SBIR $$
No

SBIR firms in the news

There are no news available.